Skip to main content

Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 2761–2775 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2527
YWHAE Gene Miller‑Dieker Lissencephaly Syndrome Genetic Test

This test analyzes the YWHAE gene for variants associated with Miller‑Dieker lissencephaly syndrome (MDLS). It provides a definitive molecular diagnosis by detecting sequence varia...

Whole Blood (EDTA), FTA Card, Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Sequence variants in the YWHAE gene", "Small deletions/duplications in the YWHAE gene", "Known pathogenic variants associated with MDLS"]
Parameters
[]
Preparation
["No specific dietary or medication restrictions are required.", "Fasting is not required.", "Continue all regular medications as prescribed."]
Indications
["Clinical suspicion of Miller‑Dieker lissencephaly syndrome (MDLS)", "Confirmation of diagnosis based on neuroimaging (agyria/pachygyria)", "Family history of MDLS", "Prenatal diagnosis or preimplantation genetic testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101107-6 ICD-10: Q04.3
Clinical summary
This test analyzes the YWHAE gene for variants associated with Miller‑Dieker lissencephaly syndrome (MDLS). It provides a definitive molecular diagnosis by detecting sequence variants, small deletions/duplications, and known pathogenic variants.
TEST-4569
ZAP70 Gene Selective T-cell Defect Genetic Test

This test identifies pathogenic variants in the ZAP70 gene associated with severe combined immunodeficiency (SCID). It analyzes the full coding region and splice sites using Next G...

Peripheral Whole Blood 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZAP70 gene", "Kinase activity disruption"]
Parameters
[]
Preparation
[]
Indications
["Suspected SCID", "Family history of ZAP70 mutation", "Carrier screening for first-degree relatives of confirmed proband"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 74698-1 ICD-10: D81.7
Clinical summary
This test identifies pathogenic variants in the ZAP70 gene associated with severe combined immunodeficiency (SCID). It analyzes the full coding region and splice sites using Next Generation Sequencing.
TEST-2711
ZBTB24 Gene ICF Syndrome Type 2 Genetic Test

This diagnostic test evaluates the ZBTB24 gene for pathogenic variants associated with Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2).

Whole blood, extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZBTB24 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["Genetic counseling session required", "Informed consent required", "Fasting is not needed"]
Indications
["Suspected Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2)", "Recurrent infections", "Distinct facial features", "Chromosomal instability"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: D82.8
Clinical summary
This diagnostic test evaluates the ZBTB24 gene for pathogenic variants associated with Immunodeficiency-Centromeric Instability-Facial Anomalies Syndrome Type 2 (ICF2).
TEST-4887
ZBTB24 Gene ICF Syndrome Type 2 Genetic Testing Test

This diagnostic test evaluates the ZBTB24 gene for mutations associated with Immunodeficiency-Centromeric Instability-Facial Anomalies (ICF) Syndrome Type 2.

Peripheral Whole Blood (EDTA or FTA Card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ZBTB24 gene mutations", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Splice-site alterations"]
Parameters
[]
Preparation
["Genetic counselling session required before sample collection", "Informed consent is mandatory"]
Indications
["Suspected ICF Syndrome Type 2", "Recurrent infections", "Facial dysmorphism", "Family history suggestive of ICF", "Neonates with low immunoglobulins"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92747-3 ICD-10: D81.8
Clinical summary
This diagnostic test evaluates the ZBTB24 gene for mutations associated with Immunodeficiency-Centromeric Instability-Facial Anomalies (ICF) Syndrome Type 2.
TEST-4782
ZCCHC12 Gene Non‑Syndromic Intellectual Disability Genetic Test

This test evaluates the ZCCHC12 gene for pathogenic variants associated with non-syndromic intellectual disability.

Peripheral Whole Blood (3-5 mL) or Saliva (2 mL) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZCCHC12 gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting required", "Provide clinical history and family pedigree chart"]
Indications
["Diagnosis of non-syndromic intellectual disability", "Genetic confirmation in individuals with developmental delay"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: F79
Clinical summary
This test evaluates the ZCCHC12 gene for pathogenic variants associated with non-syndromic intellectual disability.
TEST-4949
ZDHHC15 Gene X‑Linked Intellectual Disability Type 91 Genetic Test

This diagnostic test evaluates the ZDHHC15 gene for pathogenic variants associated with X-linked intellectual disability type 91.

Whole blood (peripheral venipuncture) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ZDHHC15 gene coding exons", "Pathogenic variants in ZDHHC15 gene flanking splice junctions"]
Parameters
[]
Preparation
["No specific fasting required.", "No specific medication or diet restrictions."]
Indications
["Males with unexplained intellectual disability, developmental delay, or autistic features.", "Family history suggestive of X-linked inheritance.", "Females with affected male relatives (for carrier status assessment)."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94847-3 ICD-10: F78.9
Clinical summary
This diagnostic test evaluates the ZDHHC15 gene for pathogenic variants associated with X-linked intellectual disability type 91.
TEST-4599
ZDHHC17 Gene Huntington Disease Genetic Test

This test evaluates the ZDHHC17 gene for variants that modify the onset and progression of Huntington disease.

Whole Blood (EDTA) or FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)", "ZDHHC17 gene sequence"]
Parameters
[{"name": "ZDHHC17 Gene Sequence", "reference_range": null}]
Preparation
["No fasting required", "Maintain normal hydration"]
Indications
["Prognostic assessment in individuals with known HTT CAG expansion", "Family cascade screening for HD modifier genes", "Research-grade data for HD studies", "Evaluation of phenotypic variability in HD families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G10
Clinical summary
This test evaluates the ZDHHC17 gene for variants that modify the onset and progression of Huntington disease.
TEST-5001
ZDHHC9 Gene Sequencing (Mental Retardation, X‑Linked Syndromic, Raymond Type) Genetic Test

This test evaluates the ZDHHC9 gene for pathogenic variants associated with X-linked syndromic mental retardation (Raymond type).

Whole Blood (EDTA) or Extracted DNA 10–14 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZDHHC9 gene", "Copy Number Variations (CNV) in the ZDHHC9 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist about anticoagulant therapy"]
Indications
["Suspected X-linked syndromic mental retardation (Raymond type)", "Family history of ZDHHC9-related disorders", "Genetic counselling for reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21624-7 ICD-10: F79
Clinical summary
This test evaluates the ZDHHC9 gene for pathogenic variants associated with X-linked syndromic mental retardation (Raymond type).
TEST-2990
ZEB2 Gene Sequencing (NGS) for Congenital Central Hypoventilation Syndrome Test

This test identifies pathogenic variants in the ZEB2 gene, providing a molecular diagnosis for congenital central hypoventilation syndrome (CCHS) and Mowat-Wilson syndrome.

Peripheral whole blood (EDTA tube), buccal swab, or pre-extracted genomic DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ZEB2 gene", "Single-nucleotide variants", "Small insertions and deletions", "Splice-site alterations"]
Parameters
[]
Preparation
[]
Indications
["Suspected diagnosis of congenital central hypoventilation syndrome (CCHS)", "Suspected diagnosis of Mowat-Wilson syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 97179-1 ICD-10: G47.35, Q87.89
Clinical summary
This test identifies pathogenic variants in the ZEB2 gene, providing a molecular diagnosis for congenital central hypoventilation syndrome (CCHS) and Mowat-Wilson syndrome.
TEST-5554
ZFHX4 Gene (Congenital Ptosis) Genetic Test

This test identifies pathogenic variants in the ZFHX4 gene associated with congenital ptosis.

Peripheral whole blood (EDTA) 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in ZFHX4 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform genetic counsellor about all medications and supplements"]
Indications
["Diagnosis of congenital ptosis", "Genetic counselling for families with ptosis", "Differentiation of isolated vs. syndromic ptosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: Q10.0
Clinical summary
This test identifies pathogenic variants in the ZFHX4 gene associated with congenital ptosis.
TEST-6061
ZFP57 Gene Maturity-Onset Diabetes of the Young (MODY) Sequencing Test

This test identifies pathogenic mutations in the ZFP57 gene, confirming a diagnosis of ZFP57-related MODY.

Whole Blood (EDTA), Extracted DNA, FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZFP57 gene", "Coding exons and splice junctions of ZFP57"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Diagnosis of Maturity-Onset Diabetes of the Young (MODY)", "Differential diagnosis of diabetes subtypes", "Identification of ZFP57 gene mutations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94531-1 ICD-10: E13.9
Clinical summary
This test identifies pathogenic mutations in the ZFP57 gene, confirming a diagnosis of ZFP57-related MODY.
TEST-4126
ZFPM2 Gene Tetralogy of Fallot Genetic Test

This test identifies genetic variants in the ZFPM2 gene associated with Tetralogy of Fallot.

Whole Blood, Extracted DNA, or One Drop Blood on FTA Card 21–28 Business Days (3–4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZFPM2 gene", "Likely pathogenic variants in the ZFPM2 gene"]
Parameters
[]
Preparation
["No fasting required", "Provide detailed clinical history", "Attend genetic counselling session (ideally)"]
Indications
["Confirmation of molecular diagnosis for Tetralogy of Fallot", "Assessment of recurrence risk in future pregnancies", "Guidance for treatment planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82332-1 ICD-10: Q21.3
Clinical summary
This test identifies genetic variants in the ZFPM2 gene associated with Tetralogy of Fallot.
TEST-5726
ZFYVE26 Gene SPG15 Genetic Test

This test identifies pathogenic variants in the ZFYVE26 gene associated with Spastic Paraplegia Type 15 (SPG15).

Whole blood, extracted DNA, dried blood spot (FTA card) 21–28 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZFYVE26 gene", "Deletion/Duplication analysis of ZFYVE26"]
Parameters
[]
Preparation
[]
Indications
["Diagnostic confirmation in symptomatic individuals with family history consistent with hereditary spastic paraplegia", "Confirming clinical suspicion of SPG15", "Reproductive planning in affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101407-3 ICD-10: G11.4
Clinical summary
This test identifies pathogenic variants in the ZFYVE26 gene associated with Spastic Paraplegia Type 15 (SPG15).
TEST-5748
ZFYVE27 Gene SPG33 Genetic Test

This test identifies pathogenic variants within the ZFYVE27 gene associated with Hereditary Spastic Paraplegia type 33 (SPG33).

Peripheral whole blood (3–5 mL in EDTA tube), Extracted DNA (2 µg minimum, >50 ng/µL), or One Drop Blood on FTA Card. 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ZFYVE27 gene variants", "Pathogenic mutations"]
Parameters
[]
Preparation
["A genetic counselling session to draw a pedigree chart of family members affected with ZFYVE27 gene SPG33 is mandatory."]
Indications
["Clinical symptoms suggestive of SPG33", "Family history of autosomal dominant inheritance of SPG33"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94719-4 ICD-10: G11.4
Clinical summary
This test identifies pathogenic variants within the ZFYVE27 gene associated with Hereditary Spastic Paraplegia type 33 (SPG33).
TEST-2908
ZIC1 Gene Craniosynostosis Type 6 Genetic Test

This test identifies pathogenic variants in the ZIC1 gene, which are associated with craniosynostosis type 6, a condition characterized by premature fusion of skull sutures.

Whole Blood (EDTA) / Extracted DNA / FTA Card 3 to 4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["ZIC1 gene sequence", "Pathogenic variants in ZIC1"]
Parameters
[]
Preparation
["Comprehensive clinical history required", "Genetic counselling session mandatory", "Disclose all current medications, supplements, and herbal preparations"]
Indications
["Suspected craniosynostosis type 6", "Family history of craniosynostosis", "Need for recurrence risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Q75.0
Clinical summary
This test identifies pathogenic variants in the ZIC1 gene, which are associated with craniosynostosis type 6, a condition characterized by premature fusion of skull sutures.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area